Leerink Swann Downgrades Allscripts-Misys Healthcare (MDRX) to Market Perform; Challenges Persist
Tweet
Share
E-mailGet Alerts MDRX Hot Sheet
Price: $4.99 +1.84%
Rating Summary:
8 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Rating Summary:
8 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Join SI Premium – FREE
Leerink Swann downgraded Allscripts-Misys Healthcare (NASDAQ: MDRX) from Outperform to Market Perform with a price target range $20-$21 from $22-23.
Analyst, David Larsen, said, "We believe that Allscripts has leading market share in the ambulatory space, and we believe the ambulatory and facility products are excellent. The brand recognition of Allscripts is very high, and we suspect that many physicians will migrate toward Allscripts over the next few years. However, we believe that the bookings bar has been set very high, at "upper-teens" growth, we estimate that with 180,000 doctors in the network, the law of large numbers is working against Allscripts, and we believe there are still technology integration challenges on both the ambulatory and inpatient side of the business."
For an analyst ratings summary and ratings history on Allscripts-Misys Healthcare click here. For more ratings news on Allscripts-Misys Healthcare click here.
Shares of Allscripts-Misys Healthcare closed at $19.54 yesterday.
Analyst, David Larsen, said, "We believe that Allscripts has leading market share in the ambulatory space, and we believe the ambulatory and facility products are excellent. The brand recognition of Allscripts is very high, and we suspect that many physicians will migrate toward Allscripts over the next few years. However, we believe that the bookings bar has been set very high, at "upper-teens" growth, we estimate that with 180,000 doctors in the network, the law of large numbers is working against Allscripts, and we believe there are still technology integration challenges on both the ambulatory and inpatient side of the business."
For an analyst ratings summary and ratings history on Allscripts-Misys Healthcare click here. For more ratings news on Allscripts-Misys Healthcare click here.
Shares of Allscripts-Misys Healthcare closed at $19.54 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- Deutsche Bank Downgrades SentinelOne Inc (S) to Hold on Valuation
- Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
